26 May 2013
Keywords: australia, first, ok, altana, alvesco-r, germany, ag
Article | 08 March 2004
Germany's Altana AG has announced that the Australian Health Agency has granted marketing approval for Alvesco (ciclesonide), a novel inhaled
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 March 2004
24 May 2013
© 2013 thepharmaletter.com